Matches in Wikidata for { <http://www.wikidata.org/entity/Q98879630> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q98879630 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q98879630 description "scientific article published on 01 September 2020" @default.
- Q98879630 description "wetenschappelijk artikel" @default.
- Q98879630 description "наукова стаття, опублікована 1 вересня 2020" @default.
- Q98879630 name "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 name "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 type Item @default.
- Q98879630 label "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 label "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 prefLabel "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 prefLabel "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 P1433 Q98879630-5B401B4E-34D6-4225-8CFA-F3B987BB8A10 @default.
- Q98879630 P1476 Q98879630-1F27DE32-28FE-46FC-9125-D0819D460470 @default.
- Q98879630 P2093 Q98879630-2339024C-28C6-4E2B-A6F2-4C055EF4E39A @default.
- Q98879630 P2093 Q98879630-2DF4D3BD-6CB8-496A-AD70-FED8B5CCD82D @default.
- Q98879630 P2093 Q98879630-8E1B43CA-774A-4AAC-A42D-BA2F7C923715 @default.
- Q98879630 P2093 Q98879630-91EF14C8-23E8-4BA5-ABF9-3585D068C3C0 @default.
- Q98879630 P31 Q98879630-42F27C83-0C6F-4C8B-B8B5-4AA8B74EF46D @default.
- Q98879630 P356 Q98879630-DE4EA777-641B-4A11-9387-951726516DB4 @default.
- Q98879630 P50 Q98879630-FCCCF1D0-B8AB-49DC-AD22-83F969C09E09 @default.
- Q98879630 P577 Q98879630-45C3A5D4-EA49-4806-BEDD-18F3DA6117F4 @default.
- Q98879630 P698 Q98879630-D6C9F384-1867-410D-ACBD-C547B5CA19D2 @default.
- Q98879630 P921 Q98879630-1B0F404A-D3C3-43BE-A9EF-72B95AF8D17C @default.
- Q98879630 P921 Q98879630-1C83C11C-9408-45EA-B6E4-5276F53308AB @default.
- Q98879630 P356 S12325-020-01476-X @default.
- Q98879630 P698 32870471 @default.
- Q98879630 P1433 Q4686392 @default.
- Q98879630 P1476 "Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis" @default.
- Q98879630 P2093 "Ataru Igarashi" @default.
- Q98879630 P2093 "Jakob Langer" @default.
- Q98879630 P2093 "Lars Wilkinson" @default.
- Q98879630 P2093 "Richard F Pollock" @default.
- Q98879630 P31 Q13442814 @default.
- Q98879630 P356 "10.1007/S12325-020-01476-X" @default.
- Q98879630 P50 Q88105426 @default.
- Q98879630 P577 "2020-09-01T00:00:00Z" @default.
- Q98879630 P698 "32870471" @default.
- Q98879630 P921 Q27261089 @default.
- Q98879630 P921 Q3025883 @default.